vs

Side-by-side financial comparison of ANAPTYSBIO, INC (ANAB) and Merchants Bancorp (MBIN). Click either name above to swap in a different company.

Merchants Bancorp is the larger business by last-quarter revenue ($175.2M vs $108.2M, roughly 1.6× ANAPTYSBIO, INC). ANAPTYSBIO, INC runs the higher net margin — 45.8% vs 38.6%, a 7.2% gap on every dollar of revenue. Over the past eight quarters, ANAPTYSBIO, INC's revenue compounded faster (288.3% CAGR vs 4.8%).

AnaptysBio, Inc. is a clinical-stage biotechnology company focused on developing antibody-based immunotherapies for inflammatory diseases, immuno-oncology indications, and rare disease conditions. It primarily serves the U.S. market, advancing its innovative product candidate pipeline to address unmet medical needs via rigorous research and clinical development.

Ameris Bancorp is an American bank holding company headquartered in Atlanta, Georgia. Through its bank subsidiary, Ameris Bank, the company operates full-service branches in Georgia, Alabama, Florida, North Carolina and South Carolina, and mortgage-only locations in Georgia, Alabama, Florida, North Carolina, South Carolina, Virginia, Maryland, and Tennessee. The company offers online and mobile banking options for both consumers and businesses.

ANAB vs MBIN — Head-to-Head

Bigger by revenue
MBIN
MBIN
1.6× larger
MBIN
$175.2M
$108.2M
ANAB
Higher net margin
ANAB
ANAB
7.2% more per $
ANAB
45.8%
38.6%
MBIN
Faster 2-yr revenue CAGR
ANAB
ANAB
Annualised
ANAB
288.3%
4.8%
MBIN

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
ANAB
ANAB
MBIN
MBIN
Revenue
$108.2M
$175.2M
Net Profit
$49.6M
$67.7M
Gross Margin
Operating Margin
61.8%
Net Margin
45.8%
38.6%
Revenue YoY
151.1%
Net Profit YoY
327.8%
16.3%
EPS (diluted)
$1.64
$1.25

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ANAB
ANAB
MBIN
MBIN
Q1 26
$175.2M
Q4 25
$108.2M
$185.3M
Q3 25
$76.3M
$171.1M
Q2 25
$22.3M
$179.2M
Q1 25
$27.8M
$145.9M
Q4 24
$43.1M
$193.8M
Q3 24
$30.0M
$149.6M
Q2 24
$11.0M
$159.5M
Net Profit
ANAB
ANAB
MBIN
MBIN
Q1 26
$67.7M
Q4 25
$49.6M
Q3 25
$15.1M
$54.7M
Q2 25
$-38.6M
$38.0M
Q1 25
$-39.3M
$58.2M
Q4 24
$-21.8M
Q3 24
$-32.9M
$61.3M
Q2 24
$-46.7M
$76.4M
Operating Margin
ANAB
ANAB
MBIN
MBIN
Q1 26
Q4 25
61.8%
39.9%
Q3 25
45.5%
37.8%
Q2 25
-117.5%
27.3%
Q1 25
-99.2%
52.4%
Q4 24
-22.4%
66.0%
Q3 24
-75.8%
54.4%
Q2 24
-367.5%
62.2%
Net Margin
ANAB
ANAB
MBIN
MBIN
Q1 26
38.6%
Q4 25
45.8%
Q3 25
19.8%
32.0%
Q2 25
-173.5%
21.2%
Q1 25
-141.6%
39.9%
Q4 24
-50.5%
Q3 24
-109.4%
41.0%
Q2 24
-425.3%
47.9%
EPS (diluted)
ANAB
ANAB
MBIN
MBIN
Q1 26
$1.25
Q4 25
$1.64
$1.28
Q3 25
$0.52
$0.97
Q2 25
$-1.34
$0.60
Q1 25
$-1.28
$0.93
Q4 24
$-0.63
$1.84
Q3 24
$-1.14
$1.17
Q2 24
$-1.71
$1.49

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ANAB
ANAB
MBIN
MBIN
Cash + ST InvestmentsLiquidity on hand
$238.2M
$83.2M
Total DebtLower is stronger
$32.0M
Stockholders' EquityBook value
$37.2M
$2.3B
Total Assets
$364.4M
$20.3B
Debt / EquityLower = less leverage
0.01×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ANAB
ANAB
MBIN
MBIN
Q1 26
$83.2M
Q4 25
$238.2M
Q3 25
$109.8M
Q2 25
$44.3M
Q1 25
$98.6M
Q4 24
$123.1M
Q3 24
$191.6M
Q2 24
$71.8M
Total Debt
ANAB
ANAB
MBIN
MBIN
Q1 26
$32.0M
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Stockholders' Equity
ANAB
ANAB
MBIN
MBIN
Q1 26
$2.3B
Q4 25
$37.2M
$2.3B
Q3 25
$-29.4M
$2.2B
Q2 25
$-44.7M
$2.2B
Q1 25
$34.0M
$2.2B
Q4 24
$70.9M
$2.2B
Q3 24
$84.4M
$1.9B
Q2 24
$9.9M
$1.9B
Total Assets
ANAB
ANAB
MBIN
MBIN
Q1 26
$20.3B
Q4 25
$364.4M
$19.4B
Q3 25
$353.1M
$19.4B
Q2 25
$335.3M
$19.1B
Q1 25
$422.1M
$18.8B
Q4 24
$483.8M
$18.8B
Q3 24
$493.4M
$18.7B
Q2 24
$427.4M
$18.2B
Debt / Equity
ANAB
ANAB
MBIN
MBIN
Q1 26
0.01×
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ANAB
ANAB
MBIN
MBIN
Operating Cash FlowLast quarter
$98.0M
Free Cash FlowOCF − Capex
$98.0M
FCF MarginFCF / Revenue
90.5%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
1.98×
TTM Free Cash FlowTrailing 4 quarters
$19.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ANAB
ANAB
MBIN
MBIN
Q1 26
Q4 25
$98.0M
$-341.2M
Q3 25
$-27.4M
$29.8M
Q2 25
$-40.2M
$-121.2M
Q1 25
$-10.7M
$148.0M
Q4 24
$-66.7M
$-835.3M
Q3 24
$-10.1M
$-492.6M
Q2 24
$-21.3M
$51.1M
Free Cash Flow
ANAB
ANAB
MBIN
MBIN
Q1 26
Q4 25
$98.0M
$-362.2M
Q3 25
$-27.4M
$24.0M
Q2 25
$-40.3M
$-125.7M
Q1 25
$-10.7M
$141.2M
Q4 24
$-66.9M
$-853.7M
Q3 24
$-10.1M
$-497.2M
Q2 24
$-21.4M
$45.8M
FCF Margin
ANAB
ANAB
MBIN
MBIN
Q1 26
Q4 25
90.5%
-195.5%
Q3 25
-35.9%
14.0%
Q2 25
-180.9%
-70.1%
Q1 25
-38.7%
96.8%
Q4 24
-155.3%
-440.6%
Q3 24
-33.7%
-332.4%
Q2 24
-194.6%
28.7%
Capex Intensity
ANAB
ANAB
MBIN
MBIN
Q1 26
Q4 25
0.0%
11.3%
Q3 25
0.0%
3.4%
Q2 25
0.2%
2.5%
Q1 25
0.1%
4.7%
Q4 24
0.6%
9.5%
Q3 24
0.1%
3.0%
Q2 24
0.3%
3.3%
Cash Conversion
ANAB
ANAB
MBIN
MBIN
Q1 26
Q4 25
1.98×
Q3 25
-1.81×
0.54×
Q2 25
-3.19×
Q1 25
2.54×
Q4 24
Q3 24
-8.04×
Q2 24
0.67×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ANAB
ANAB

Segment breakdown not available.

MBIN
MBIN

Net Interest Income$128.6M73%
Noninterest Income$46.6M27%

Related Comparisons